Press release
Generalized Myasthenia Gravis (gMG) Market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.1 billion by 2034
Generalized Myasthenia Gravis (gMG) Market
The Generalized Myasthenia Gravis (gMG) market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.1 billion by 2034, growing at a CAGR of around 9.8%. Growth is driven by the rapid adoption of biologics, antibody-targeted therapies, and improved diagnostic awareness for autoimmune neuromuscular disorders.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72089
Key Market Drivers
• Rising global prevalence of autoimmune neuromuscular diseases.
• Strong adoption of complement inhibitors, FcRn inhibitors, and monoclonal antibodies.
• Growing availability of specialty neurology centers and improved treatment guidelines.
• Increased diagnosis through advanced antibody testing (AChR, MuSK, LRP4).
Challenges
• Very high cost of biologic therapies.
• Long-term treatment dependency increases healthcare burden.
• Limited specialist availability in developing regions.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72089/generalized-myasthenia-gravis-gmg-market
Market Segmentation
By Treatment
• Monoclonal antibodies (FcRn & complement inhibitors)
• Immunosuppressants
• Corticosteroids
• Plasma exchange / IVIG
By Diagnosis
• Antibody testing
• Electrophysiology testing
• Imaging / clinical evaluation
By End User
• Hospitals
• Neurology clinics
• Homecare (for maintenance therapies)
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72089
Regional Snapshot
• North America leads due to strong adoption of FcRn and complement inhibitors.
• Europe shows steady growth supported by reimbursement and guideline-based care.
• Asia-Pacific is the fastest-growing region as awareness and biologic access improve.
Key Companies
Alexion (AstraZeneca), Argenx, Roche, Novartis, UCB, Johnson & Johnson, Takeda, Pfizer.
Future Outlook
The market will expand rapidly as new FcRn inhibitors, complement blockers, and next-generation immunotherapies gain approvals. Wider specialist access, earlier diagnosis, and improved affordability models will further drive adoption worldwide.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72089
Our More Reports:
Diamond Blackfan Anemia Market
https://exactitudeconsultancy.com/reports/71277/diamond-blackfan-anemia-market
Fanconi Anemia Market
https://exactitudeconsultancy.com/reports/71277/diamond-blackfan-anemia-market
Hemophilia B Market
https://exactitudeconsultancy.com/reports/71654/hemophilia-b-market
Hepatorenal Syndrome Market
https://exactitudeconsultancy.com/reports/71283/hepatorenal-syndrome-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generalized Myasthenia Gravis (gMG) Market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.1 billion by 2034 here
News-ID: 4310985 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Generalized
Generalized Anxiety Disorder Market Outlook USD 1,810.25M
Generalized Anxiety Disorder Market Gains Momentum as Advances in Therapy Transform Mental Healthcare
Introduction: Rising Focus on Anxiety Disorders in Global Mental Health
Generalized Anxiety Disorder (GAD) is one of the most prevalent and persistent mental health conditions worldwide, characterized by excessive, uncontrollable worry lasting six months or longer, often accompanied by physical symptoms such as fatigue, restlessness, muscle tension, and sleep disturbances. Unlike situational anxiety, GAD significantly impacts daily functioning, work…
Key Trends Reshaping the Generalized Anxiety Disorder Market: Innovative Drug De …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Generalized Anxiety Disorder Market Size Growth Forecast: What to Expect by 2025?
The market encompassing generalized anxiety disorder has experienced consistent expansion over the preceding years, projected to increase its valuation from $7.76 billion in 2024 to $7.93 billion in the subsequent year, reflecting a compound annual growth rate…
Key Trends Influencing the Growth of the Generalized Anxiety Disorder Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Generalized Anxiety Disorder Market Through 2025?
In recent years, there has been a consistent expansion in the market size for generalized anxiety disorder. The market, which is predicted to grow from $7.76 billion in 2024 to $8.01 billion in 2025, will experience…
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev …
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billion…
Generalized Anxiety Disorder Market Report and Forecast 2024-2032
Generalized Anxiety Disorder Market Outlook
The generalized anxiety disorder market size in the 7 major markets was valued at USD 1717.5 million in 2023, driven by the increasing advancements in psychotherapeutic as well as pharmacological treatment options for patients. The market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1809.8 million in 2024 to USD 2751.1…
